Release of GLP-1 in responseto an ingested meal and glucose load plays a major role in the development of impaired insulin secretion.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Medicare Plans Face Higher Liability From Cap on Out-of-Pocket Drug Costs
Read More
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
Listen
Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says
FDA Approves First Treatment for Chronic Inflammatory Lung Condition
FDA Approves Ajovy for Childhood Migraine Prevention
FDA Grants Accelerated Approval For Targeted Drug for Rare Brain Tumor